An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

HIV-1 particles are released from ... This causes a huge structural rearrangement of the virus components. For many years, scientists have explored the structural changes of the virus capsid which ...

The presence of the central DNA flap in HIV vectors enhances gene ... vector molecules per cell. The flap structure probably allows the reverse-transcribed genome to be actively transported ...

Host cells, in turn, protect their genome ... structure-guided experiments. Through this, they were able to show that the copia retrotransposon adopts a capsid fold similar to the mature capsid of ...

Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a global outbreak. This was the first time many had ever heard of the virus, ...

Sometimes, the most significant scientific discoveries happen by accident. Scientists have long known that whole-genome ...

A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...

About 640 000 children have been orphaned by the virus. Picture: AFP Health advocacy groups have welcomed the HIV-Aids clinical trial showing HIV patients can control the virus without using ...

He found an answer in SARS-CoV-2, the virus responsible ... papers published on HIV in the same period. Scientists have also generated more than 17 million SARS-CoV-2 genome sequences so far ...

“We are finding the 3D structure of the genome,” said Satoshi Namekawa, professor of microbiology and molecular genetics at the University of California, Davis and senior author on one of the ...